Country-of-birth disparities in high-grade endometrial cancer: A European-first population-based analysis on incidence, age at presentation, and survival in an equal-access health system in the Netherlands

Read full text Summarise with VIRAT
Authors: Janneke J.E. Kieviet, Johanna M. A. Pijnenborg, Maaike A. van der Aa, Henrica M.J. Werner, Johannes W. Trum, Olga L. van der Hel, Marcus J. Rijken
Cited by: 0
References: 35

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

INTRODUCTION: Endometrial cancer (EC) incidence and outcomes vary globally, with ethnic disparities well-studied in the United States but less documented in Europe. This study aimed to investigate disparities in incidence of high-grade EC, age at diagnosis, and survival among women diagnosed with EC in the Netherlands, stratified by country of birth. METHODOLOGY: We conducted a population-based cohort study including all patients diagnosed with primary EC in the Netherlands Cancer Registry between 2010 and 2022 (n = 25 834). Patients were categorized by integrated country-of-birth groups. Descriptive statistical analysis, logistic regression (to calculate odds ratios (ORs) with confidence intervals (CIs) for high-grade EC diagnosis, adjusting for age, body mass index, and year of diagnosis) and survival analyses were performed. RESULTS: Median age of diagnosis for high-grade EC was lower for patients born outside the Netherlands compared to Dutch-born patients. Patients born in Africa (OR 2.02; CI1.54-2.64), Surinam & Dutch Caribbean (OR 2.09; CI1.76-2.48), America & Oceania (OR 1.98; CI1.32-2.94), Asia (OR 1.57; CI1.32-1.87), and Turkey (OR 1.39; CI1.04-1.86) had significantly higher baseline-adjusted risk for high-grade EC compared to Dutch-born patients. Survival analyses showed increased risk of death for patients born in Surinam & Dutch Caribbean (HR 1.39; CI1.16-1.68), Asia (HR 1.51; CI1.26-1.82), and Europe (HR 1.22; CI1.02-1.46) after adjusting for age, BMI, histology, and stage. CONCLUSIONS: The significant disparities in the incidence of high-grade EC, with worse survival of EC by country of birth, underline the urgent need to further study the role of ethnicity in tailored diagnostic and treatment approach.

Fields of Study & Subjects

Endometrial and Cervical Cancer Treatments Global Cancer Incidence and Screening Cancer Risks and Factors

Publication details

Journal / source
European Journal of Cancer
Volume
239
Pages
116698–116698
Publication date
25 March 2026
Language
EN